The UK’s National Health Service is rolling out a meningitis B vaccination campaign targeting approximately one million young people across England. The initiative was prompted by an outbreak in Kent, where 29 confirmed or suspected cases and two deaths occurred in March. Nearly 90,000 doses have already been administered, with 135,000 additional appointments scheduled in the coming weeks.
The vaccine is being made available free of charge to 17 and 18-year-olds, as well as students under age 25 who are enrolled in residential colleges or universities for the first time this autumn. Vaccination services can be accessed through high street pharmacies and the NHS National Booking Service for those already registered with a general practitioner. Walk-in appointments are available at participating pharmacies for eligible individuals.
The two-dose vaccine, administered at least 28 days apart, provides protection against meningitis B, a dangerous bacterial strain. Common side effects include mild fever, nausea, headache, or muscle aches that typically resolve within one to two days. Serious adverse effects are rare, and the vaccine cannot cause meningitis as it contains no live bacteria. Both doses are necessary for optimal protection.
Health authorities emphasize that first-year university students face a risk approximately seven times higher than their non-attending peers due to increased social mixing and shared living arrangements. Meningitis B can cause severe complications including inflammation of the brain lining, blood poisoning, and potentially fatal outcomes. The vaccine was added to routine childhood immunizations for babies born after 1 July 2015, but older teenagers and young adults previously missed this protection. UK vaccine experts have suggested that government consider routinely offering the vaccine to teenagers around age 15, though such decisions remain with individual nations within the UK.
Each nation—England, Scotland, Wales, and Northern Ireland—has developed its own implementation plans, with most offering vaccination to young people completing final secondary school years in summer 2026.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI